"Women coming off weight loss injections in midlife need to be particularly strategic about their approach," Rachael adds. "The hormonal shifts of midlife can reduce muscle protein synthesis by up to ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

The drug is still going through trials, but the medical company Lilly, behind it, is hopeful it can be rolled out soon. In ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.

A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...

Eli Lilly's new oral weight loss pill, orforglipron, shows promise in Phase 3 trials, offering a convenient alternative to ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

It's hard to believe just six years ago we were in the middle of a 'body positivity' movement. Catwalks featured models with ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

Employers face rising GLP-1 demand. Here are tips to manage costs while maintaining care access.